Government Expands Anti-Drug Operations and Rehabilitation Network in Jammu & Kashmir

Date:

Share post:

The Union Ministry of Social Justice and Empowerment has reaffirmed its commitment to combating substance abuse in Jammu & Kashmir by expanding regional rehabilitation infrastructure and strengthening inter-agency anti-drug coordination. The initiatives are executed under the National Action Plan for Drug Demand Reduction (NAPDDR).

In a written response to the Rajya Sabha, Minister of State Shri B. L. Verma outlined the functional infrastructure currently supporting the Union Territory. Jammu & Kashmir currently operates 21 Addiction Treatment Facilities (ATFs), six District De-Addiction Centres (DDACs), one Integrated Rehabilitation Centre for Addicts (IRCA), three Outreach and Drop-In Centres (ODICs), and two Community-based Peer-Led Intervention (CPLI) centres. While the government continuously monitors and establishes new treatment facilities, officials clarified that there is currently no proposal to create combined de-addiction and vocational training facilities in the Jammu region.

Parallel to demand reduction efforts, law enforcement agencies are intensifying measures against illegal drug trafficking through the Ministry of Home Affairs’ four-tier Narco Coordination Centre (NCORD) framework. Designed to unify strategy across Apex, Executive, State/UT, and District levels, the NCORD mechanism facilitates seamless data sharing and operational reviews between central and state authorities. Since 2018, Jammu & Kashmir has convened 17 State-Level and 836 District-Level NCORD meetings to monitor local enforcement actions.

Supported by the centralized NCORD Portal a digital platform serving as a knowledge repository across all four tiers the Government continues to integrate law enforcement with healthcare solutions to tackle substance abuse comprehensively.

Written by: Pragna Biswas

Graphics by: Pramit Hazra

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related articles

Apollo Hospitals Launches ‘Always Open, Always Here’, A Global First in Healthcare From India

Avalon Pharma and Bio-Thera Solutions, Ltd. announced an exclusive licensing and commercialization agreement for BAT2406, a proposed biosimilar...

AMTZ LTD Celebrates a Decade of Transforming Healthcare Innovation and Indigenous Manufacturing

AMTZ LTD marks a historic milestone as it completes 10 remarkable years of pioneering innovation, manufacturing excellence, and...

ViiV Healthcare Advances HIV Care with Breakthrough Long-Acting Injectable Data at AIDS 2026

ViiV Healthcare, the global specialist HIV company majority-owned by GSK plc, announced landmark clinical, real-world, and pipeline data...

Wockhardt Launches “Wockhardt Antibiotic Academy” to Tackle Growing Threat of Multidrug Resistance in India

Wockhardt Limited announced the launch of the Wockhardt Antibiotic Academy, a national initiative dedicated to fostering patient-centric scientific dialogue...